Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinance

Tech & Science

PredictLive141AccountSocial
MARKETSPERPSLIVE141

Medicine

Product
Kalshi ProPerpetual FuturesMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
All markets
AI
Big Tech & Business
Education
Energy
Market Share
Medicine
Physics & Math
Public Health
Space

Will the FDA approve retatrutide?

Before Jan 1, 2028
1.38x
Before Jul 1, 2027
5.25x
$70,200 vol

When will the FDA reclassify BPC-157 to Category 1?

Before 2027
4.13x
Before November
13.4x
$116,389 vol

When will Compass Pathways submit a NDA for COMP360 psilocybin?

before December
2.24x
before April 2027
1.16x
$26,210 vol

When will Beam Therapeutics submit a BLA for Risto-cel?

before 2027
1.90x
before December
2.89x
$25,113 vol

Will the FDA approve VERVE-102?

Before 2030
1.70x
Before 2031
1.42x
$1,735 vol

Will the FDA approve a cure for Type 1 diabetes before 2033?

Yes
2.46x
No
1.52x
$10,581 vol

Will the FDA approve CagriSema?

Before Jan 1, 2027
1.38x
Before Jan 1, 2028
1.06x
$9,037 vol

When will the FDA approve Intellia Therapeutics’ lonvo-z?

Before July 2027
1.09x
Before 2028
1.08x
$6,560 vol

When will the FDA approve Compass Pathways’ COMP360 Psilocybin?

Before Mar 1, 2027
1.50x
Before Jan 1, 2027
3.96x
$24,203 vol